PERRONE, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 148
EU - Europa 65
AS - Asia 28
OC - Oceania 1
SA - Sud America 1
Totale 243
Nazione #
US - Stati Uniti d'America 145
IT - Italia 19
CN - Cina 12
GB - Regno Unito 10
FR - Francia 9
PL - Polonia 8
VN - Vietnam 8
DE - Germania 6
CA - Canada 3
KR - Corea 3
RU - Federazione Russa 3
BE - Belgio 2
CZ - Repubblica Ceca 2
JP - Giappone 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
ES - Italia 1
FI - Finlandia 1
IR - Iran 1
SE - Svezia 1
TW - Taiwan 1
Totale 243
Città #
Fairfield 21
Woodbridge 16
Santa Cruz 14
Dong Ket 8
Ashburn 7
Seattle 7
Houston 6
Wilmington 6
Cambridge 5
Chicago 5
Ann Arbor 4
Buffalo 4
Kraków 4
Pisa 4
Torino 4
Warsaw 4
Hangzhou 3
Las Vegas 3
London 3
Council Bluffs 2
Foshan 2
Liverpool 2
Milton Keynes 2
Morinodai 2
Nanjing 2
New York 2
Shanghai 2
University Park 2
Berlin 1
Boardman 1
Bowie 1
Brentwood 1
Burlington 1
Böblingen 1
Clearwater 1
Columbus 1
Cosenza 1
Crugers 1
Des Moines 1
Erlangen 1
Flinders 1
Florence 1
Frankfurt am Main 1
Gothenburg 1
Helsinki 1
Henderson 1
Iglesias 1
Jacksonville 1
Lake Forest 1
Mislata 1
Napoli 1
Newbury Park 1
Nijmegen 1
Ottawa 1
Paris 1
Portland 1
San Francisco 1
San Pablo 1
Seoul 1
Sofia 1
Taipei 1
Toronto 1
Turin 1
Totale 181
Nome #
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016, file e27ce42d-d0be-2581-e053-d805fe0acbaa 141
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients, file e27ce42c-bc15-2581-e053-d805fe0acbaa 118
Totale 259
Categoria #
all - tutte 418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 8 11
2019/202034 3 4 0 7 4 2 2 4 4 1 2 1
2020/202178 2 3 3 28 2 3 10 2 12 2 6 5
2021/202253 7 2 2 1 5 2 5 5 1 3 17 3
2022/202339 1 0 12 9 1 3 0 4 2 0 5 2
2023/202419 4 2 1 1 2 1 3 2 2 1 0 0
Totale 259